Effectiveness of hormonal intrauterine system in treatment of pelvic congestion syndrome compared to oral progestin

Abdelhamid M Abdel Rahim, Annisa Rahim, Diaa Eldeen M. Abd El Aal, Mohamed Fathalla, Mohammed Nagy Elammary, Hossam O. Hamed
In: Journal of Endometriosis and Pelvic Pain Disorders · 2025 · doi:10.1177/22840265251387844 · W4416126910
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This study found that a levonorgestrel-releasing intrauterine system (LNG-IUS) was more effective than oral progestin in reducing pelvic pain for patients with pelvic congestion syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-08 · read from full text ⓘ

The provided text is a metadata page for an article titled "Effectiveness of hormonal intrauterine system in treatment of pelvic congestion syndrome compared to oral progestin," published in the Journal of Endometriosis and Pelvic Pain Disorders. It does not contain the abstract, methods, results, or conclusions of the study itself, but rather displays access options, citation metrics, and links to related content such as comments on the paper. Consequently, no specific findings regarding the comparison between hormonal intrauterine systems and oral progestins can be extracted from this snippet. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Purpose: To compare levonorgestrel-releasing intrauterine system (LNG-IUS) with oral progestin in reducing pain associated with pelvic congestion syndrome (PCS). Methods: A comparative cohort study included 104 patients with PCS who allocated to LNG-IUS (Group 1, n = 52) or oral norethisterone acetate 10 mg twice daily (Group 2, n = 52). Follow-up was carried out for 4 months from starting treatment. Pelvic pain was assessed by the Visual Analog Scale (VAS) and the ovarian and uterine vein diameter was assessed by pelvic Doppler ultrasound. The primary outcome was the improvement of pelvic pain. The secondary outcomes included the need for additional pain treatment, pelvic veins’ diameters, and the menstrual flow. Results: More patients in LNG-IUS had experienced lower degrees of pain severity by VAS compared to oral progestin ( p = 0.029). The posttreatment pain relief was positively correlated with pretreatment pain severity in LNG-IUS ( p = 0.039) and oral progestin group ( p = 0.0001) while it was negatively correlated with pretreatment uterine vein diameter in oral progestin group ( p = 0.01). The need for additional pain treatment was less with LNG-IUS ( p = 0.049). Compared to pretreatment, both LNG-IUS and oral progestin resulted in decrease in ovarian ( p = 0.044 and 0.013, respectively) and uterine vein diameters ( p = 0.001 and 0.001, respectively). The posttreatment menstrual blood flow was lighter in LNG-IUS group ( p = 0.1). Conclusions: LNG-IUS is more effective in relieving pain in PCS compared with oral progestin. This effect cannot be attributed solely to decrease in pelvic veins’ diameters. These promising results underscore the need for randomized studies with longer follow-up to demonstrate sustainable effectiveness.
Full text 1,541 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose:

Methods

Results:

Conclusions

Get full access to this article View all access and purchase options for this article. Data availability statement

References

Cite Cite Cite Download to reference manager If you have citation software installed, you can download citation data to the citation manager of your choice Information, rights and permissions Information Published In

Keywords

Data availability statement Authors Author contributions Metrics and citations Metrics Journals metrics This article was published in Journal of Endometriosis and Pelvic Pain Disorders. View All Journal MetricsPublication usage* Total views and downloads: 43 *Publication usage tracking started in December 2016 Publications citing this one Receive email alerts when this publication is cited Web of Science: 1 view articles Opens in new tab Crossref: 1 - Comments on ‘Effectiveness of hormonal intrauterine system in treatment of pelvic congestion syndrome compared to oral progestin’ Figures and tables Figures & Media Tables View Options Access options If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below: loading institutional access options Alternatively, view purchase options below: Purchase 24 hour online access to view and download content. Access journal content via a DeepDyve subscription or find out more about this option.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

VAS-pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-09-20T06:29:17.529187+00:00
License: CC0 · commercial use OK